Thus, 14-3-3 binding to CdGAP may behave as an important negative regulator of CdGAP transcriptional activity by cytosolic sequestration, leading to the inhibition of epithelial-to-mesenchymal transition (EMT), cell motility and invasion of breast cancer cells. Here, ARHGAP31 is linked to breast carcinoma.